Formula: | C24H27FN2O |
Molecular Weight: | 378.49 |
Rotatable Bond Donors: | 2 |
clogP: | 5.11 |
Topological Polar Surface Area: | 28.26 |
Lipinski's RO5: | MW: 378.49 HBA: 3 HBD: 1 RB: 2 LogP: 5.11 |
Rule of Three: | MW: 378.49 HBA: 3 HBD: 1 RB: 2 LogP: 5.11 |
|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC3950145 | 1.0 | ZINC3950145 RDKit 3D 28 32 0 0 0 0 0 0 0 0999 V2000 -2.9486 -0.7872 2.7905 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.3442 -1.3137 1.5773 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.8922 -2.6438 1.3651 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5672 -0.4287 0.4145 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0382 -0.2080 0.0802 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.7613 0.8438 0.6581 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.1102 1.0384 0.3675 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.7620 0.1764 -0.5081 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.0658 -0.8776 -1.0902 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.7171 -1.0662 -0.7951 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.9127 0.9330 0.6947 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4068 0.8548 0.8590 C 0 0 0 0 0 0 0 0 0 0 0 0 0.2593 0.2338 -0.3571 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3582 -1.1188 -0.6612 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8649 -1.0302 -0.8124 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0518 1.0742 -1.5145 O 0 0 0 0 0 0 0 0 0 0 0 0 0.7764 2.3144 -1.4436 C 0 0 0 0 0 0 0 0 0 0 0 0 2.2913 2.0967 -1.5514 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6819 0.9657 -0.6795 C 0 0 0 0 0 0 0 0 0 0 0 0 1.7259 0.1218 -0.1555 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3608 -0.8131 0.6037 N 0 0 0 0 0 0 0 0 0 0 0 0 3.7178 -0.5993 0.5792 C 0 0 0 0 0 0 0 0 0 0 0 0 4.7465 -1.3095 1.2064 C 0 0 0 0 0 0 0 0 0 0 0 0 6.0504 -0.8558 0.9998 C 0 0 0 0 0 0 0 0 0 0 0 0 6.3008 0.2549 0.2031 C 0 0 0 0 0 0 0 0 0 0 0 0 7.5665 0.6618 0.0297 F 0 0 0 0 0 0 0 0 0 0 0 0 5.2709 0.9605 -0.4206 C 0 0 0 0 0 0 0 0 0 0 0 0 3.9490 0.5216 -0.2274 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 2 4 1 0 4 5 1 0 5 6 2 0 6 7 1 0 7 8 2 0 8 9 1 0 9 10 2 0 4 11 1 0 11 12 1 0 12 13 1 0 13 14 1 0 14 15 1 0 13 16 1 0 16 17 1 0 17 18 1 0 18 19 1 0 19 20 2 0 20 21 1 0 21 22 1 0 22 23 2 0 23 24 1 0 24 25 2 0 25 26 1 0 25 27 1 0 27 28 2 0 15 4 1 0 28 19 1 0 10 5 1 0 20 13 1 0 28 22 1 0 M END $$$$ | ||
ZINC2054774212 | 1.0 | ZINC2054774212 RDKit 3D 28 32 0 0 0 0 0 0 0 0999 V2000 -1.5841 1.1804 -1.9291 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5431 -0.0146 -1.1003 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.1550 -1.0875 -1.8685 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.2059 0.1864 0.2044 C 0 0 2 0 0 0 0 0 0 0 0 0 -3.6720 0.5903 0.0964 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.6832 -0.3764 0.0159 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.0234 -0.0125 -0.0996 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.3754 1.3323 -0.1404 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3887 2.3098 -0.0666 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0506 1.9386 0.0487 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4347 1.2862 0.9440 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.5448 0.8394 2.0830 C 0 0 0 0 0 0 0 0 0 0 0 0 0.1899 -0.4690 1.8657 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.6942 -1.5615 1.2918 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1130 -1.1119 1.0150 C 0 0 0 0 0 0 0 0 0 0 0 0 0.6227 -0.8815 3.1857 O 0 0 0 0 0 0 0 0 0 0 0 0 1.5233 -2.0019 3.1625 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8858 -1.6169 2.5749 C 0 0 0 0 0 0 0 0 0 0 0 0 2.6718 -0.8179 1.3476 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5595 -0.4412 0.3094 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9240 -0.6638 0.0533 C 0 0 0 0 0 0 0 0 0 0 0 0 5.4758 -0.1242 -1.1094 C 0 0 0 0 0 0 0 0 0 0 0 0 6.7756 -0.3279 -1.3683 F 0 0 0 0 0 0 0 0 0 0 0 0 4.7155 0.6165 -2.0063 C 0 0 0 0 0 0 0 0 0 0 0 0 3.3589 0.8489 -1.7737 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8113 0.3067 -0.6068 C 0 0 0 0 0 0 0 0 0 0 0 0 1.5257 0.3694 -0.1285 N 0 0 0 0 0 0 0 0 0 0 0 0 1.4283 -0.2961 1.0555 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 4 2 1 6 4 5 1 0 5 6 2 0 6 7 1 0 7 8 2 0 8 9 1 0 9 10 2 0 4 11 1 0 11 12 1 0 13 12 1 1 13 14 1 0 14 15 1 0 13 16 1 0 16 17 1 0 17 18 1 0 18 19 1 0 19 20 1 0 20 21 2 0 21 22 1 0 22 23 1 0 22 24 2 0 24 25 1 0 25 26 2 0 26 27 1 0 27 28 1 0 15 4 1 0 28 19 2 0 10 5 1 0 28 13 1 0 26 20 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |